277 related articles for article (PubMed ID: 33859287)
1. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.
LaVigne JE; Hecksel R; Keresztes A; Streicher JM
Sci Rep; 2021 Apr; 11(1):8232. PubMed ID: 33859287
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of Cannabis sativa terpenes in rats.
Carey LM; Ghodrati S; France CP
Behav Pharmacol; 2024 Jun; 35(4):161-171. PubMed ID: 38660819
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
5. Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function.
Sbarski B; Akirav I
Eur Neuropsychopharmacol; 2018 Aug; 28(8):955-969. PubMed ID: 30026011
[TBL] [Abstract][Full Text] [Related]
6. Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Dong C; Tian Z; Zhang K; Chang L; Qu Y; Pu Y; Ren Q; Fujita Y; Ohgi Y; Futamura T; Hashimoto K
Pharmacol Biochem Behav; 2019 Feb; 177():61-68. PubMed ID: 30629965
[TBL] [Abstract][Full Text] [Related]
7. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
8. Terpenoids, Cannabimimetic Ligands, beyond the
Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
[TBL] [Abstract][Full Text] [Related]
9. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
[TBL] [Abstract][Full Text] [Related]
11. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
12. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.
Wiley JL; Marusich JA; Huffman JW
Life Sci; 2014 Feb; 97(1):55-63. PubMed ID: 24071522
[TBL] [Abstract][Full Text] [Related]
13. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
[TBL] [Abstract][Full Text] [Related]
14. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice.
Rein JL; Mackie K; Kleyman TR; Satlin LM
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F917-F930. PubMed ID: 38634131
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
17. Supraspinal interaction between HIV-1-gp120 and cannabinoid analgesic effectiveness.
Palma J; Narasimhan M; Guindon J; Benamar K
Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1157-1161. PubMed ID: 30008083
[TBL] [Abstract][Full Text] [Related]
18. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
[TBL] [Abstract][Full Text] [Related]
19. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
20. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
